Replies to post #254003 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

"Once official meeting minutes are received from the FDA, the Company expects to release more details regarding planned Phase 3 trials of Brilacidin as a novel oral SOM treatment. Conducted in accordance with the FDA guidance, the goal of the upcoming studies will be to satisfy requirements for a New Drug Application and, ultimately, obtain marketing approval of Brilacidin for SOM. Management further intends to solicit international regulatory bodies for the purpose of expanded registration globally."

From PR on Dec 17th. We should hear soon. IMO

[loanranger]

I thought so. Do you know why Revance was given the Prurisol treatment in his bio?
http://www.ipharminc.com/senior-management/